Literature DB >> 11056381

Inhibitory effects of ML-9, wortmannin, and Y-27632 on the chemotaxis of vascular smooth muscle cells in response to platelet-derived growth factor-BB.

H Kishi1, J Bao, K Kohama.   

Abstract

The chemotactic migration toward platelet-derived growth factor-BB of SM3, a cell line established from rabbit aorta smooth muscle, was examined by the Boyden chamber method. Myosin light-chain (MLC) kinase inhibitors ML-9 and wortmannin, and the Rho kinase inhibitor Y-27632 effectively reduced the migration. However, neither membrane ruffling nor the phosphorylation of MLC was inhibited concomitantly. The reduction is discussed with reference to a novel property of MLC kinase, which stimulates myosin ATPase activity without phosphorylating MLC [Ye et al. (1999) Proc. Natl. Acad. Sci. USA 96, 6666-6671].

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056381     DOI: 10.1093/oxfordjournals.jbchem.a022806

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.

Authors:  Khatuna Gabunia; Surbhi Jain; Ross N England; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

2.  Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit.

Authors:  Masato Naraoka; Akira Munakata; Naoya Matsuda; Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-01-29       Impact factor: 6.829

3.  Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration.

Authors:  Boda Zhou; Lingyun Zu; Yong Chen; Xilong Zheng; Yuhui Wang; Bing Pan; Min Dong; Enchen Zhou; Mingming Zhao; Youyi Zhang; Lemin Zheng; Wei Gao
Journal:  Lipids Health Dis       Date:  2017-01-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.